Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
22 Cards in this Set
- Front
- Back
What is Phosphatidylinositol (PIP2) hydrolyzed/degraded by and what is released?
|
- PI-Phospholipase C (PI-PLC)
- DAG and IP3 are released (secondary messengers) - IP3 releases intracellular stores of Ca |
|
What do DAG and Ca activate? What does this product do?
|
- Calcium-Dependent Protein Kinase C (PKC)
- Phosphorylates multiple intracellular proteins |
|
How is DAG recycled back into PIP2?
|
- DAG phosphorylated by ATP
- Produces Phosphatidic Acid - CTP added to create CDP- Diglyceride - Inositol added to create PI - PI phosphorylated twice to create PIP2 |
|
What are the major and minor pathways to liberate Arachindonic Acid from Membrane Phospholipid?
|
Major:
- Stimulus binds to receptor - PLA2, activated with Ca, modifies Phosphatidylcholine to Arachindonic Acid Minor - Stimulus binds to receptor - PLC modifies Phosphatidylinositol bisphosphate to DAG - DAG lipase creates Arachidonic Acid and Monoacylglycerol - Monoacylglycerol lipase modifies monoacylglycerol to Aranchindonic Acid |
|
What are Cyclooxygenase's (COX) 2 Activities?
|
Cyclooxygenase Activity: adds O2
Peroxidase Activity (synthesizes PGH2) |
|
What are Eicosanoids?
|
Family of oxygenated arachidonic acid derivatives that interact with specific receptors to amplify/propagate flow of biological information
|
|
Pathway to synthesize Prostacyclin (PGI2) from Arachindonic Acid
|
- Add COX (O2 activity) to Arachidonic Acid
- PGG2 - Add COX (peroxidase activity) to PGG2 - PGH2 - Add PGI synthase to PGH2 - Prostacyclin |
|
Pathway to synthesize Thromboxane (TXA2) from Arachindonic Acid
|
- Add COX (O2 activity) to Arachidonic Acid
- PGG2 - Add COX (peroxidase activity) to PGG2 - PGH2 - Add Thromboxane synthase to PGH2 - Thromboxane |
|
What does Prostacyclin (PGI2) do?
|
- produced by endothelial cells (as is PGE2)
- increases vasodilation and decreases platelet aggregation |
|
What does Thromboxane (TXA2) do?
|
- produced by platelets
- increases vasoconstriction and platelet aggregation |
|
NSAIDS
- Activity of Aspirin |
- Inhibits platelet COX 1 (prevents platelet aggregation, TXA2)
- creates irreversible covalent bond by acetylation, so COX is a dead end product |
|
NSAIDS
- Activity of Ibuprofen |
- Inhibits the binding of Arachidonic Acid to COX 1 and II (the O2 activity)
- competitive inhibition, thus reversible - Celebrex/Vioxx works same way |
|
Activity of Acetominophen (not an NSAID)
|
- Inhibits COX by acting on CNS
- Rapidly degraded, so not an anti-inflammatory |
|
NSAID uses and drawbacks
|
- Treats inflammation and pain
- May cause ulcers |
|
Purpose of COX I and II in GI tract
|
- mediate the secretion of bicarbonate and mucous
|
|
Low doses of Aspirin
|
- Inhibits the platelets from making thromboxane (doesn't effect endothelial cells)
- Less Thromboxane but high PIP2 - Increases platelet turnover and prevents MI |
|
PIP2 vs TXA2
|
- Antagonistic properties regarding aggregation of platelets and vascular tone
- important in hemostatic response and atherosclerosis |
|
Synthetic Pathway for Leukotrienes
|
- 5-Lipoxygenase modifies Arachidonic Acid into 5-HPETE
- 5-HPETE reduced to 5-HETE -5-HETE to LTA4 - With addition of glutathione residue to LTA4 it breaks into LTC4 and LTB4 - LTC4 can break into its derivatives LTD4 and LTE4 |
|
What are the Peptidoleukotrienes?
|
LTC4
LTD4 LTE4 |
|
What does LTB4 do in anaphylaxis?
|
- Increases vascular permeability (swelling) and T-cell proliferation (inflammation), etc
|
|
What does LTC4 and LTD4 do in anaphylaxis?
|
- Increases bronchoconstriction and vascular permeability
|
|
What biological function do leukotrienes (LT) participate in?
|
anaphylaxis
|